
12/01/2023
Cipla launches Palbociclib capsules (125mg, 100 mg & 75mg) in India for the treatment of 1st and 2nd Line Hormone Receptor Positive HER2- Metastatic Breast Cancer.
pharmaceutical industry's
Bhopal
462010
Be the first to know and let us send you an email when drx.n.singh posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to drx.n.singh: